Familial aggregation of clinical and neurocognitive features in sibling pairs with and without schizophrenia
- PMID: 19398304
- PMCID: PMC2813565
- DOI: 10.1016/j.schres.2009.03.030
Familial aggregation of clinical and neurocognitive features in sibling pairs with and without schizophrenia
Abstract
Objective: Neurocognitive impairment was found to be heritable in individuals with schizophrenia and their relatives. However, the heritability of neurocognitive measures in families with and without schizophrenia has not been directly compared. In this study, we examined the genetic structure of clinical and neurocognitive measures in sibling pairs with and without schizophrenia to test the hypothesis that the familial aggregation of such measures may be altered by having schizophrenia.
Method: A total of 278 subjects including patients with schizophrenia and their non-psychotic full siblings, healthy controls, and their full siblings were recruited. Heritability was estimated for working memory, episodic memory, executive function and attention, as well as clinical features, such as positive, negative and disorganization symptoms.
Results: Many clinical and cognitive domains were impaired in subjects with schizophrenia and their non psychotic siblings. Negative symptoms, working memory, episodic memory and executive function, but not positive, disorganization symptoms and attention, were found to be significantly heritable in all sibling pairs. However, the heritability of working memory function was significantly (chi(2)((d.f.=6))=13.9, p=.031) decreased in proband sibling pairs (h(2)=.38) as compared to control sibling pairs (h(2)=.95). Significant genetic correlations were observed between negative symptoms and the cluster of working memory, episodic memory and executive function.
Conclusions: Several neurocognitive measures were heritable in sibling pairs with and without schizophrenia. However, schizophrenia reduced the heritability of working memory, perhaps due to disease-related environmental or genetic factors. Evidence for potential pleiotropy will inform future phenotypic studies.
Conflict of interest statement
Dr. Csernansky has received research grants from the NIMH and NIA, and royalties from Medtronic for a patent held jointly with Washington University School of Medicine, has been a paid consultant for Eli Lilly and Sanofi-Aventis, and has received speakers’ honoraria from Janssen Pharmaceutica, Eli Lilly and Bristol-Myers Squibb. Dr. Deanna Barch has received grants from the NIMH, NIA, NARSAD and the McDonnel Center for Systems Neuroscience. All other authors declare that they have no conflict of interest.
Figures

Comment in
-
Re: Familial aggregation of clinical and neurocognitive features in sibling pairs with and without schizophrenia.Schizophr Res. 2010 Feb;116(2-3):289-90. doi: 10.1016/j.schres.2009.08.019. Epub 2009 Nov 17. Schizophr Res. 2010. PMID: 19926455 Free PMC article. No abstract available.
Similar articles
-
Neuropsychological performance and auditory event related potentials in schizophrenia patients and their siblings: a family study.Schizophr Res. 2011 Aug;130(1-3):195-202. doi: 10.1016/j.schres.2011.04.018. Epub 2011 May 17. Schizophr Res. 2011. PMID: 21592733
-
Factors mediating cognitive deficits and psychopathology among siblings of individuals with schizophrenia.Schizophr Bull. 2006 Jul;32(3):525-37. doi: 10.1093/schbul/sbj082. Epub 2006 May 19. Schizophr Bull. 2006. PMID: 16714471 Free PMC article.
-
Factor structures of the neurocognitive assessments and familial analysis in first-episode schizophrenia patients, their relatives and controls.Aust N Z J Psychiatry. 2010 Feb;44(2):109-19. doi: 10.3109/00048670903270381. Aust N Z J Psychiatry. 2010. PMID: 20113299
-
Language processing and memory in ill and well siblings from multiplex families affected with schizophrenia.Schizophr Res. 1997 May 3;25(1):43-52. doi: 10.1016/s0920-9964(97)00004-2. Schizophr Res. 1997. PMID: 9176926
-
Neurocognition in youth and young adults under age 30 at familial risk for schizophrenia: a quantitative and qualitative review.Cogn Neuropsychiatry. 2013;18(1-2):44-82. doi: 10.1080/13546805.2012.676309. Epub 2012 Sep 21. Cogn Neuropsychiatry. 2013. PMID: 22998599 Free PMC article. Review.
Cited by
-
Bipolar disorder risk gene FOXO6 modulates negative symptoms in schizophrenia: a neuroimaging genetics study.J Psychiatry Neurosci. 2017 May;42(3):172-180. doi: 10.1503/jpn.150332. J Psychiatry Neurosci. 2017. PMID: 28234206 Free PMC article.
-
Prefrontal deviations in function but not volume are putative endophenotypes for schizophrenia.Brain. 2012 Jul;135(Pt 7):2231-44. doi: 10.1093/brain/aws138. Epub 2012 Jun 12. Brain. 2012. PMID: 22693145 Free PMC article.
-
Deviation from expected cognitive ability across psychotic disorders.Schizophr Res. 2018 Feb;192:300-307. doi: 10.1016/j.schres.2017.05.019. Epub 2017 May 22. Schizophr Res. 2018. PMID: 28545944 Free PMC article.
-
Heterozygous deletion of the LRFN2 gene is associated with working memory deficits.Eur J Hum Genet. 2016 Jun;24(6):911-8. doi: 10.1038/ejhg.2015.221. Epub 2015 Oct 21. Eur J Hum Genet. 2016. PMID: 26486473 Free PMC article.
-
Re: Familial aggregation of clinical and neurocognitive features in sibling pairs with and without schizophrenia.Schizophr Res. 2010 Feb;116(2-3):289-90. doi: 10.1016/j.schres.2009.08.019. Epub 2009 Nov 17. Schizophr Res. 2010. PMID: 19926455 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical